Informed Consent Disclosures and Minimum Requirements in AI Clinical Trials: Cross-Sectional Analysis
Journal of Medical Internet Research · 2026
DOI: 10.2196/94504 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Medical Internet Research, 2026. Verfasst von Hankun Su und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, Xiangya Hospital Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Artificial Intelligence, Informed Consent, Clinical Trials as Topic, Disclosure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The integration of artificial intelligence (AI) into clinical research challenges traditional informed consent (IC) frameworks due to the algorithmic complexity, opacity, and adaptive nature of AI systems. Although public demand for transparency regarding AI use in health care is high, current ethical guidelines lack specificity, and there has been no assessment of AI representation in IC documentation within clinical trial registries.
Objective
This study aimed to evaluate the prevalence, clarity, and completeness of AI-related consent disclosures in clinical trials registered on ClinicalTrials.gov and to propose a framework for enhanced patient digital literacy and ethical robustness.
Methods
We conducted a cross-sectional content analysis of 114 AI-involving clinical trials with publicly available IC documents from ClinicalTrials.gov (search conducted on June 21, 2025). We assessed AI-specific disclosures, readability (using the Simple Measure of Gobbledygook index), document length, visual aid use, and data governance protocols against World Health Organization and National Institutes of Health standards. We also refined an AI risk framework encompassing model autonomy, deviation from standards of care, patient-facing interaction, and clinical risk, scoring each trial on a 3-tier scale.
Results
More than half (66/114, 58%) of ICs failed to disclose the AI type or its intended use, and 18.4% (n=21) omitted risks entirely. Discrepancy was observed between trial registry entries and IC reporting of AI methods. Only 14% (n=16) of ICs met the dual criteria of brevity (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Reproductive Medicine, Xiangya Hospital Central South University, Changsha, Hunan, China.
- Clinical Research Center for Women's Reproductive Health in Hunan Province, Changsha, Hunan, China.
ORCID-Profile: Hankun Su, Fen Xiao, Hoksan Chau, Yuqian Tong, Siyi Han, Xinyu Cheng, Zhilin Che, Liye Sun, Yuemeng Yang, Jing Zhao, Yanping Li, Hui Li
Zitieren
APA
Su, H., Xiao, F., Chau, H., Tong, Y., Han, S., Cheng, X., Che, Z., Sun, L., Yang, Y., Zhao, J., Li, Y., & Li, H. (2026). Informed Consent Disclosures and Minimum Requirements in AI Clinical Trials: Cross-Sectional Analysis. Journal of Medical Internet Research. https://doi.org/10.2196/94504
Vancouver
Su H, Xiao F, Chau H, Tong Y, Han S, Cheng X, et al. Informed Consent Disclosures and Minimum Requirements in AI Clinical Trials: Cross-Sectional Analysis. Journal of Medical Internet Research. 2026. doi:10.2196/94504
BibTeX
@article{Su2026,
author = {Su, Hankun and Xiao, Fen and Chau, Hoksan and Tong, Yuqian and Han, Siyi and Cheng, Xinyu and Che, Zhilin and Sun, Liye and Yang, Yuemeng and Zhao, Jing and Li, Yanping and Li, Hui},
title = {Informed Consent Disclosures and Minimum Requirements in AI Clinical Trials: Cross-Sectional Analysis},
journal = {Journal of Medical Internet Research},
year = {2026},
doi = {10.2196/94504}
}
EUVIMED